These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 17428648

  • 1. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L.
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [Abstract] [Full Text] [Related]

  • 2. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G, Berg M, Jüngerkes F, Diehl L, Sullivan BA, Kronenberg M, Limmer A, Knolle PA.
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [Abstract] [Full Text] [Related]

  • 3. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J, Berntman E, Stenström M, Smith EM, Månsson R, Stenstad H, Yamagata T, Agace W, Sigvardsson M, Cardell SL.
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [Abstract] [Full Text] [Related]

  • 4. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
    Hansen DS, Siomos MA, De Koning-Ward T, Buckingham L, Crabb BS, Schofield L.
    Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
    [Abstract] [Full Text] [Related]

  • 7. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.
    Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR.
    Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536
    [Abstract] [Full Text] [Related]

  • 8. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E, Alonso C, Solana R.
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [Abstract] [Full Text] [Related]

  • 9. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
    Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A.
    Nature; 2005 Mar 24; 434(7032):525-9. PubMed ID: 15791258
    [Abstract] [Full Text] [Related]

  • 10. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A, Wigren M, Hultgårdh-Nilsson A, Saxena A, Gomez MF, Cardell S, Fredrikson GN, Nilsson J.
    Circ Res; 2007 Oct 12; 101(8):e83-9. PubMed ID: 17885216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD1d expression by hepatocytes is a main restriction element for intrahepatic T-cell recognition.
    Agrati C, Martini F, Nisii C, Oliva A, D'Offizi G, Narciso P, Nardacci R, Piacentini M, Dieli F, Pucillo LP, Poccia F.
    J Biol Regul Homeost Agents; 2005 Oct 12; 19(1-2):41-8. PubMed ID: 16178273
    [Abstract] [Full Text] [Related]

  • 14. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity.
    Zeissig S, Kaser A, Dougan SK, Nieuwenhuis EE, Blumberg RS.
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec 12; 293(6):G1101-5. PubMed ID: 17717040
    [Abstract] [Full Text] [Related]

  • 15. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
    Florence WC, Bhat RK, Joyce S.
    Expert Rev Mol Med; 2008 Jul 07; 10():e20. PubMed ID: 18601810
    [Abstract] [Full Text] [Related]

  • 16. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
    Dufour FD, Silveira PA, Baxter AG.
    J Immunotoxicol; 2008 Apr 07; 5(2):249-57. PubMed ID: 18569396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The in vivo response of invariant natural killer T cells to glycolipid antigens.
    Parekh VV, Lalani S, Van Kaer L.
    Int Rev Immunol; 2007 Apr 07; 26(1-2):31-48. PubMed ID: 17454263
    [Abstract] [Full Text] [Related]

  • 19. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, Casorati G, Dellabona P, Abrignani S.
    J Exp Med; 2003 Apr 21; 197(8):1051-7. PubMed ID: 12695492
    [Abstract] [Full Text] [Related]

  • 20. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM, Palmer JL, Gamelli RL, Faunce DE.
    Shock; 2008 Feb 21; 29(2):269-77. PubMed ID: 17693934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.